I immensely enjoy helping companies and institutions translate ground-breaking scientific innovations into strong, creative and dynamic intellectual property assets to gain a competitive edge, maximize revenue and meet long-term business objectives.
mpavao@cooley.com
Dr. Matthew Pavao advises public and private companies, including early stage companies, as well as research and educational institutions, on all aspects of intellectual property to maximize revenue and meet their business objectives.
Download full bio
Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche
Reata Pharmaceuticals – $505 Million Follow-On Offering
ERYTECH – $144 Million IPO
Selecta Biosciences – $74 Million IPO
Inotek Pharmaceuticals – $50 Million Follow-On
View all
Intellectual Property
Patent Counseling & Prosecution – Life Sciences
Patent Office Litigation
Life Sciences
Medtech
Family
Traveling
Beer Brewing
Scuba Diving
Matthew provides helpful, well thought-out counsel. He is extremely practical and very creative.
Suffolk UniversityJD, magna cum laude, 2006
Boston University PhD, Biochemistry2001
Boston University MA, Medical Sciences1995
University of MassachusettsBS, Biology, Zoologycum laude, 1993
Massachusetts
U.S. Patent and Trademark Office
Oculis and European Biotech Acquisition Corp. Announce Business Combination Agreement October 25, 2022
Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche August 5, 2022
Chambers USA 2022 Recognizes Cooley Lawyers + Practices June 2, 2022
Boston Patent Law Association
American Intellectual Property Law Association
Chambers: Leading Patent Lawyer
IAM Patent 1000: Top Patent Lawyer
Super Lawyers: Leading IP Lawyer
+1 617 937 2340
Locations